Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial (Q33389011)

26 July 2017

Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial (English)

1 reference

26 July 2017

0 references

1 reference

chronic liver disease

0 references

author

Adrian M. Di Bisceglie

9

object named as

Adrian M Di Bisceglie

1 reference

26 July 2017

10

Herbert L Bonkovsky

1 reference

26 July 2017

3

Timothy R Morgan

1 reference

26 July 2017

Leonard B Seeff

1

1 reference

26 July 2017

Gregory T Everson

2

1 reference

26 July 2017

Teresa M Curto

4

1 reference

26 July 2017

William M Lee

5

1 reference

26 July 2017

Marc G Ghany

6

1 reference

26 July 2017

Mitchell L Shiffman

7

1 reference

26 July 2017

Robert J Fontana

8

1 reference

26 July 2017

Jules L Dienstag

11

1 reference

26 July 2017

HALT–C Trial Group

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Clinical Gastroenterology and Hepatology

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

877-883

1 reference

26 July 2017

10

1 reference

Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

The role of liver biopsy in chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Liver biopsy:complications and risk factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Outcome of patients hospitalized for complications after outpatient liver biopsy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Histological grading and staging of chronic hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Bleeding after liver biopsy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

A 21-year experience with major hemorrhage after percutaneous liver biopsy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Tests of coagulation in liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Interlaboratory variability in assessment of the model of end-stage liver disease score

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771318

Liver biopsy in cirrhotic patients

31 October 2018

1 reference

12 December 2020

Fine-needle liver biopsy in patients with severely impaired coagulation

1 reference

12 December 2020

1 reference

12 December 2020

The risk of bleeding after percutaneous liver biopsy: relation to platelet count

1 reference

12 December 2020

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

12 December 2020

Bleeding after liver biopsy does not correlate with indices of peripheral coagulation

1 reference

12 December 2020

10.1016/J.CGH.2010.03.025

Identifiers

DOI

1 reference

26 July 2017

1 reference

26 July 2017

1 reference